Exciting News: Peer-Reviewed Publication of Groundbreaking Cancer Protocol

Exciting News: Peer-Reviewed Publication of Groundbreaking Cancer Protocol

We are pleased to announce that the first-of-its-kind protocol utilizing Ivermectin, Mebendazole, and Fenbendazole for cancer treatment has been peer-reviewed and officially published on September 19, 2024.

This study and protocol align with the work the Beat Cancer Foundation has been advocating and educating clients about for nearly five years Our focus on metabolic therapies, non-toxic repurposed drugs, and integrative treatments has contributed to improved survival times, disease stabilization, and our ultimate goal—achieving complete remission.

We would like to extend our deepest gratitude to the lead authors, Dr. Ilyes Baghli and Dr. Pierrick Martinez, for their groundbreaking contributions to advancing new therapeutic strategies for cancer.

https://isom.ca/article/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment-a-hybrid-orthomolecular-protocol/